Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hepatitis B Vaccination Schedules in HIV-infected Persons
NCT00230061Phase 4Completed
- Sponsor
- Erasmus MC
- Start
- Apr 2004
- Primary completion
- May 2008
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of Recombivax HB in hepatitis B (HBV) (2 arms), sponsored by Erasmus MC. Primary endpoint: Measurement of anti-Hbs titer after completing hepatitis B vaccination. Started Apr 2004; status: completed.
02
Drugs
Recombivax HB
03
Conditions
hepatitis B (HBV)
Beyond the preview
Go deeper on NCT00230061.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00230061.